Wiley Bros.-aintree Capital »

Biomarin Pharmaceutical shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $28k 35k 0.79
2025-06-30 $28k 30k 0.94

More positions owned by Wiley Bros.-aintree Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Ishares Tr Msci Usa Qlt Fct (QUAL)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical